THOMPSON SIEGEL & WALMSLEY LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1008322
RICHMOND, VA
Position in VRTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,874,377
-$162,228 QoQ
Shares Held
6,437
-3.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $58,024,470 across 5 Biotechnology names. VRTX ranks #3 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
233,694 | $44,179,850 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,676 | $9,793,984 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,437 | $2,874,377 | |
| 4 | VIR |
Vir Biotechnology, Inc.
|
92,000 | $824,320 | |
| 5 | FENC |
Fennec Pharmaceuticals Inc.
|
57,226 | $351,939 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,874,377 | 6,437 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,036,605 | 6,698 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,664,326 | 6,803 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,058,524 | 6,870 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $3,446,585 | 7,109 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,915,145 | 7,239 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $3,366,714 | 7,239 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,398,220 | 7,250 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $3,086,585 | 7,384 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $3,471,992 | 8,533 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $3,025,338 | 8,700 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $3,159,447 | 8,978 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,028,452 | 9,612 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,016,884 | 10,447 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,253,271 | 11,236 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $3,653,689 | 12,966 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $5,425,043 | 20,788 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $9,236,815 | 42,062 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $8,180,869 | 45,101 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,271,180 | 36,062 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $283,654 | 1,320 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $74,210 | 314 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $96,330 | 354 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $102,769 | 354 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $84,234 | 354 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||